JAK2 and hepatocellular carcinoma: It is reported that the abnormally activated JAK2/STAT3 signaling pathway enhances the occurrence and development of HCC by promoting tumor cell proliferation, migration, invasion, angiogenesis, and apoptosis inhibition (Kang et al. 2021).